Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Borghini

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Therapeutische Umschau. Revue Therapeutique|June 1, 1990
[A favorable hyperlipoproteinemia: high-density lipoproteins and atherosclerosis]R W James, I Borghini
Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)|January 1, 1993
Lipoprotein complexes in human cerebrospinal fluidI Borghini, D Pometta, R W James
Schweizerische Medizinische Wochenschrift|December 16, 1989
[Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes]I Borghini, R W James, D Pometta
Biochimica Et Biophysica Acta|March 16, 1995
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluidI Borghini, F Barja, D Pometta, et al.
Biochimica Et Biophysica Acta|May 8, 1991
Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implicationsI Borghini, R W James, M C Blatter, et al.
Tropical Medicine & International Health : TM & IH|March 8, 2012
Optimal dose finding for novel antimalarial combination therapyS Duparc, C Lanza, D Ubben, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
In vivo phosphorylation of the Na,K-ATPase alpha subunit in sciatic nerves of control and diabetic rats: effects of protein kinase modulatorsI Borghini, K Geering, A Gjinovci, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2003
Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot studyP Rutgeerts, L Lemmens, G Van Assche, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1991
Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysisR W James, A C Hochstrasser, I Borghini, et al.
Biochimica Et Biophysica Acta|January 16, 1990
A novel high-density lipoprotein particle and associated protein in rat plasmaM C Blatter, R W James, I Borghini, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Therapeutische Umschau. Revue Therapeutique|June 1, 1990
[A favorable hyperlipoproteinemia: high-density lipoproteins and atherosclerosis]R W James, I Borghini
Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)|January 1, 1993
Lipoprotein complexes in human cerebrospinal fluidI Borghini, D Pometta, R W James
Schweizerische Medizinische Wochenschrift|December 16, 1989
[Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes]I Borghini, R W James, D Pometta
Biochimica Et Biophysica Acta|March 16, 1995
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluidI Borghini, F Barja, D Pometta, et al.
Biochimica Et Biophysica Acta|May 8, 1991
Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implicationsI Borghini, R W James, M C Blatter, et al.
Tropical Medicine & International Health : TM & IH|March 8, 2012
Optimal dose finding for novel antimalarial combination therapyS Duparc, C Lanza, D Ubben, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
In vivo phosphorylation of the Na,K-ATPase alpha subunit in sciatic nerves of control and diabetic rats: effects of protein kinase modulatorsI Borghini, K Geering, A Gjinovci, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2003
Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot studyP Rutgeerts, L Lemmens, G Van Assche, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1991
Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysisR W James, A C Hochstrasser, I Borghini, et al.
Biochimica Et Biophysica Acta|January 16, 1990
A novel high-density lipoprotein particle and associated protein in rat plasmaM C Blatter, R W James, I Borghini, et al.
Pageof 2